MedTrace Logo

Post Market TRUST Study

NCT01563783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2023-02-01

No results posted yet for this study

Summary

This Post Market study is being conducted to compare the direct and indirect cost of three approaches (GFA, myomectomy, and uterine artery embolization) for the treatment of symptomatic uterine fibroids.

Conditions

  • Uterine Fibroids

Interventions

PROCEDURE

Global Fibroid Ablation (GFA)

GFA is being used for the treatment of symptomatic uterine fibroids

PROCEDURE

Abdominal or Laparoscopic Myomectomy

Myomectomy is a procedure in which uterine fibroids are surgically removed from the uterus.

PROCEDURE

Uterine Artery Embolization (UAE)

UAE is a minimally invasive surgical procedure used to treat uterine fibroids.

Sponsors & Collaborators

  • Acessa Health, Inc.

    lead INDUSTRY

Principal Investigators

  • John Thiel, MD · Saskatchewan Health Authority - Regina Area

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-09-30
Completion
2022-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01563783 on ClinicalTrials.gov